Walking out of hospital is not the same as recovering

Christine Buckley has spent more than twenty years listening to people who survived a ruptured aneurysm. Her message to clinicians is uncomfortable in its simplicity: the patient who walks out of your unit talking and moving may be profoundly changed, and nobody around them can see it. Fatigue, noise and light sensitivity, a working day that can no longer be finished, relationships that quietly bend. None of that appears on a modified Rankin score.

She is Executive Director of the Brain Aneurysm Foundation, the largest private funder of brain aneurysm research in the US and Canada, and host of The 1 in 50 podcast. In this conversation with ISAH convener Oli Flower she covers the awareness gap, the stigma survivors carry back to work, and why haemorrhagic stroke still sits in the shadow of BE FAST.

Worth listening for

• Her 30-second ask of every clinician: never forget what the patient, or the person caring for them, is telling you.

• The board chairman sent home with sleeping tablets and painkillers, who ruptured on day six.

• Why a woman who returned to work after breast cancer and then after an aneurysm found the second recovery harder: people rallied for the first and doubted her after the second.

• The funding question. Ischaemic stroke has a public education pathway and corporate money behind it. Haemorrhagic stroke, so far, does not.

Where this shows up in the program

ISAH 2026 has been built so this perspective runs through the meeting rather than closing it. The first plenary on Wednesday morning is Philip Talbot on the forgotten survivors. On Friday afternoon, the ISAH Futures session opens with Christine Buckley and Simone Russell on how foundations can improve outcomes, followed by Rethinking Recovery Beyond mRS, drawing on international surveys and workshops with survivors, and the results of the core measurement instrument working groups.

The day before the conference, Tuesday 17 November, Shane English and Chris Andersen run a full-day consensus workshop that brings people with lived experience, researchers and clinicians together to agree the core outcome set every future aSAH trial should report. If you have ever wondered why fewer than one in ten SAH trials measure quality of life, that room is where the answer gets fixed.

September is Brain Aneurysm Awareness Month. Christine’s request is a simple one: talk about it, share reliable information, and follow the Brain Aneurysm Foundation.

Listen above, or go to the full episode and transcript on NeuroResus.

ISAH 2026 runs 17–20 November at the Sheraton Grand Hyde Park, Sydney. See the program or register here.